A Review of Olanzapine in the Treatment of Cancer Anorexia-Cachexia Syndrome
Background: Cancer anorexia-cachexia syndrome (CAS) is a multifactorial condition that is highly prevalent in advanced cancer patients and associated with significant reduction in functional performance, reduction in quality of life, and increased mortality. Currently, no medications are approved fo...
Saved in:
Main Authors: | Ivy O. Poon (Author), Veronica Ajewole (Author), Ursula K. Braun (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome
by: Mantovani G, et al.
Published: (2013) -
Drugs in development for treatment of patients with cancer-related anorexia and cachexia syndrome [Retraction]
by: Mantovani G, et al.
Published: (2013) -
Megestrol acetate for cachexia-anorexia syndrome. A systematic review
by: Vicente Ruiz‐García, et al.
Published: (2018) -
IUPHAR ECR review: Cancer-related anorexia-cachexia in cancer patients: Pathophysiology and treatment
by: Iftekhar Hossain Chowdhury, et al.
Published: (2024) -
Rikkunshito, a ghrelin potentiator, ameliorates anorexia-cachexia syndrome
by: Naoki eFujitsuka, et al.
Published: (2014)